ES2125331T3 - Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida. - Google Patents

Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.

Info

Publication number
ES2125331T3
ES2125331T3 ES93905520T ES93905520T ES2125331T3 ES 2125331 T3 ES2125331 T3 ES 2125331T3 ES 93905520 T ES93905520 T ES 93905520T ES 93905520 T ES93905520 T ES 93905520T ES 2125331 T3 ES2125331 T3 ES 2125331T3
Authority
ES
Spain
Prior art keywords
aids
vaccae
hiv infection
micobacterium
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905520T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Application granted granted Critical
Publication of ES2125331T3 publication Critical patent/ES2125331T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL INVENTO SE REFIERE AL EMPLEO DE MATERIAL ANTIGENICO Y/O INMUNOREGULATORIO DERIVADO DE MYCOBACTERIUM VACCAE PARA TRATAMIENTO DE INFECCION DE HIV CON O SIN AIDS Y CON O SIN TUBERCULOSIS ASOCIADA.
ES93905520T 1992-09-14 1993-03-05 Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida. Expired - Lifetime ES2125331T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use

Publications (1)

Publication Number Publication Date
ES2125331T3 true ES2125331T3 (es) 1999-03-01

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905520T Expired - Lifetime ES2125331T3 (es) 1992-09-14 1993-03-05 Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.

Country Status (17)

Country Link
EP (1) EP0661998B1 (es)
JP (1) JPH06100457A (es)
KR (1) KR100272743B1 (es)
CN (1) CN1060937C (es)
AP (1) AP510A (es)
AT (1) ATE173633T1 (es)
AU (1) AU683835B2 (es)
BR (1) BR9303762A (es)
CA (1) CA2105646A1 (es)
DE (1) DE69322280T2 (es)
DK (1) DK0661998T3 (es)
ES (1) ES2125331T3 (es)
GB (1) GB9219425D0 (es)
RU (1) RU2106878C1 (es)
SG (1) SG72610A1 (es)
WO (1) WO1994006466A1 (es)
ZA (1) ZA935575B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
RU2197989C2 (ru) * 1996-12-18 2003-02-10 Стэнфорд Рук Лимитед ПРИМЕНЕНИЕ Mycobacterium vaccae ДЛЯ РЕГУЛЯЦИИ ПО ТИПУ ОТРИЦАТЕЛЬНОЙ ОБРАТНОЙ СВЯЗИ Th2-АКТИВНОСТИ ИММУННОЙ СИСТЕМЫ
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
EA200300784A1 (ru) * 2001-01-17 2004-10-28 Бакулиш Мафатлал Хамар Способ лечения заболевания/инфекции вирусом иммунодефицита человека (вич)
ATE425759T1 (de) * 2001-01-17 2009-04-15 Mafatlal Khamar Bakulesh Immunomodulator zur bekampfung von durch humanen immunschwachevirus (hiv) vermittelte krankheiten/infektionen
WO2003063897A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
KR20050008452A (ko) * 2002-03-08 2005-01-21 바쿠레시 마파탈 카마르 결핵의 치료방법
RU2380114C1 (ru) * 2008-06-25 2010-01-27 Людмила Анатольевна Шовкун Способ лечения туберкулеза легких у больных вич-инфекцией
JP7760151B2 (ja) * 2021-09-09 2025-10-27 国立大学法人東京海洋大学 抗酸菌症用ｄｎａワクチン及びそれを用いた抗酸菌症の予防方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use

Also Published As

Publication number Publication date
EP0661998A1 (en) 1995-07-12
CN1089478A (zh) 1994-07-20
AP9300555A0 (en) 1993-10-31
SG72610A1 (en) 2001-07-24
CN1060937C (zh) 2001-01-24
JPH06100457A (ja) 1994-04-12
EP0661998B1 (en) 1998-11-25
DE69322280T2 (de) 1999-04-22
GB9219425D0 (en) 1992-10-28
DK0661998T3 (da) 1999-08-09
WO1994006466A1 (en) 1994-03-31
AU683835B2 (en) 1997-11-27
ZA935575B (en) 1994-03-01
RU2106878C1 (ru) 1998-03-20
AP510A (en) 1996-07-23
KR100272743B1 (ko) 2000-11-15
ATE173633T1 (de) 1998-12-15
KR950703360A (ko) 1995-09-20
BR9303762A (pt) 1994-03-22
AU3642093A (en) 1994-04-12
CA2105646A1 (en) 1994-03-15
DE69322280D1 (de) 1999-01-07
HK1011289A1 (en) 1999-07-09

Similar Documents

Publication Publication Date Title
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
DE69116377D1 (de) Mycobacterium vaccae in der behandlung von uveitis
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
MX9701385A (es) Preparacion de producto combinado para usarse en enfermedades inmunologicas.
ES2103105T3 (es) Cosmeticos mejorados para el cuidado de la piel.
IT7921626A0 (it) Elemento d'abbigliamento o accessorio previsto per adattarsi con aderenza ad una parte del corpo umano e procedimentoper adattare il detto elemento o accessorio alla detta parte del corpo umano.
UA35583C2 (uk) Застосування антигенного та/або імунорегулюючого матеріалу, одержаного з mycobacterium vaccаe, для лікування психічного захворювання, зв`язаного з аутоімунною реакцією, викликаною інфекцією
AU3204489A (en) A synthetic antigen evoking anti-hiv response
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
ES2088431T3 (es) Preparacion biologica y su utilizacion.
AU571003B2 (en) Scalp treatment by lipase application
BR9303762A (pt) Uso de material antigenico e/ou imunorregulatorio derivado de mycobacterium vaccae,processo para o tratamento de infeccao por hiv com ou sem aids,produtos e agente imunoterapeutico
EP0222302A3 (en) Strain of aureobasidium pullulans, preparation process and use
PE5596A1 (es) Agente antivirosico
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
ES2127761T3 (es) Vacuna contra la dermatomicosis.
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
GR3001850T3 (en) Expellants of phytopathogenic microbes
FR2410476B1 (fr) Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
ES2051621A1 (es) Procedimiento de obtencion de vacuna frente a estafilococos.
Chain B. Bloom That is less than clear. We have done virtually no otherantigens. B. Askonas I do remember that you used to havesuppression to Con A responses.
IL123382A0 (en) Preparation for the prophylaxis and/or treatment of wool and hair loss

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661998

Country of ref document: ES